Cumulative false-positives (FP) in the prostate, lung, colorectal, ovarian (PLCO) cancer screening trial

被引:0
|
作者
Miller, J. H.
Kramer, B. S.
Kreimer, A. R.
Prorok, P. C.
Xu, J.
Baker, S. G.
Fagerstrom, R.
Berg, C. D.
Gohagan, J. K.
机构
[1] NIH, Rockville, MD USA
[2] NCI, Rockville, MD USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1503
引用
收藏
页数:1
相关论文
共 50 条
  • [1] The prostate, lung, colorectal and ovarian (PLCO) cancer screening trial - Preface
    Gohagan, JK
    [J]. CONTROLLED CLINICAL TRIALS, 2000, 21 (06): : 249S - 250S
  • [2] Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
    Prorok, PC
    Andriole, GL
    Bresalier, RS
    Buys, SS
    Chia, D
    Crawford, ED
    Fogel, R
    Gelmann, EP
    Gilbert, F
    Hasson, MA
    Hayes, RB
    Johnson, CC
    Mandel, JS
    Oberman, A
    O'Brien, B
    Oken, MM
    Rafla, S
    Reding, D
    Rutt, W
    Weissfeld, JL
    Yokochi, L
    Gohagan, JK
    [J]. CONTROLLED CLINICAL TRIALS, 2000, 21 (06): : 273S - 309S
  • [3] Lung Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial
    Hocking, William G.
    Hu, Ping
    Oken, Martin M.
    Winslow, Stephen D.
    Kvale, Paul A.
    Prorok, Philip C.
    Ragard, Lawrence R.
    Commins, John
    Lynch, David A.
    Andriole, Gerald L.
    Buys, Saundra S.
    Fouad, Mona N.
    Fuhrman, Carl R.
    Isaacs, Claudine
    Yokochi, Lance A.
    Riley, Thomas L.
    Pinsky, Paul F.
    Gohagan, John K.
    Berg, Christine D.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (10) : 722 - 731
  • [4] Black participation in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
    Stallings, FL
    Ford, ME
    Simpson, NK
    Fouad, M
    Jernigan, JC
    Trauth, JM
    Miller, DS
    [J]. CONTROLLED CLINICAL TRIALS, 2000, 21 (06): : 379S - 389S
  • [5] Prostate cancer specific survival in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial
    Pinsky, Paul F.
    Black, Amanda
    Parnes, Howard L.
    Grubb, Robert
    Crawford, E. David
    Miller, Anthony
    Reding, Douglas
    Andriole, Gerald
    [J]. CANCER EPIDEMIOLOGY, 2012, 36 (06) : E401 - E406
  • [6] Pathologic findings following false-positive screening tests for ovarian cancer in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial
    Nyante, Sarah J.
    Black, Amanda
    Kreimer, Aimee R.
    Duggan, Maire A.
    Carreon, J. Daniel
    Kessel, Bruce
    Buys, Saundra S.
    Ragard, Lawrence R.
    Johnson, Karen A.
    Dunn, Barbara K.
    Lamerato, Lois
    Commins, John M.
    Berg, Christine D.
    Sherman, Mark E.
    [J]. GYNECOLOGIC ONCOLOGY, 2011, 120 (03) : 474 - 479
  • [7] Secondary prostate cancer screening outcomes by race in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Screening Trial
    Miller, Eric A.
    Pinsky, Paul F.
    Black, Amanda
    Andriole, Gerald L.
    Pierre-Victor, Dudith
    [J]. PROSTATE, 2018, 78 (11): : 830 - 838
  • [8] Measuring the impact of HIPAA in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial
    Marcus, PM
    Miedzinksi, M
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (02) : 549 - 549
  • [9] Death review process in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
    Miller, AB
    Yurgalevitch, S
    Weissfeld, JL
    [J]. CONTROLLED CLINICAL TRIALS, 2000, 21 (06): : 400S - 406S
  • [10] The Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial Pathology Tissue Resource
    Zhu, Claire S.
    Huang, Wen-Yi
    Pinsky, Paulf F.
    Berg, Christine D.
    Sherman, Mark
    Yu, Kelly J.
    Carrick, Danielle M.
    Black, Amanda
    Hoover, Robert
    Lenz, Petra
    Williams, Craig
    Hawkins, Laura
    Chaloux, Matthew
    Yurgalevitch, Susan
    Mathew, Sunitha
    Miller, Amy
    Olivo, Vanessa
    Khan, Asia
    Pretzel, Shannon M.
    Multerer, Deborah
    Beckmann, Patricia
    Broski, Karen G.
    Freedman, Neal D.
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2016, 25 (12) : 1635 - 1642